Antimicrobial treatment duration for uncomplicated bloodstream infections in critically ill children: a multicentre observational study

Antimicrobial treatment duration for uncomplicated bloodstream infections in critically ill children: a multicentre observational study

Abstract Background Bloodstream infections (BSIs) cause significant morbidity and mortality in critically ill children but treatment duration is understudied. We describe the durations of antimicrobial treatment that critically ill children receive and explore factors associated with treatment durat...

Full description

Bibliographic Details
Main Authors: Sandra Pong, Robert A. Fowler, Srinivas Murthy, Jeffrey M. Pernica, Elaine Gilfoyle, Patricia Fontela, Asgar H. Rishu, Nicholas Mitsakakis, James S. Hutchison, Michelle Science, Winnie Seto, Philippe Jouvet, Nick Daneman, on behalf of the Canadian Critical Care Trials Group
Format: Article
Language:English
Published: BMC 2022-04-01
Series:BMC Pediatrics
Subjects:
Antibacterial agents
Bacteremia
Critical care
Critical illness
Duration of therapy
Pediatric
Online Access:https://doi.org/10.1186/s12887-022-03219-z

Internet

https://doi.org/10.1186/s12887-022-03219-z

Similar Items